 |
Tranilast |
|---|---|
| Trade Name | Rizaben |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2003-12-02 00:00:00 |
| Sponsor | Angiogen Pharmaceuticals, Pty. Ltd.;Level 31, ABN AMRO Tower, 88 Phillip Street Sydney, N.S.W. 2000; |
Related Access Program